Naked Science Forum

Life Sciences => Physiology & Medicine => Topic started by: James_Lilly911 on 12/02/2018 12:31:51

Title: What is Kymriah, the cell therapy for ALL and AML blood cancers?
Post by: James_Lilly911 on 12/02/2018 12:31:51

Hi there folks. I am interested if anybody has more information or know sources where I can read more about a new drug called Kymriah (tisagenlecleucel) by Novartis.


In general, this drug is a brand new way of Oncology diseases treatment especially acute lymphoblastic leukemia and others that need hematopoietic cells transplantation or have a high risk of relapse. If someone knows something special about CTR or such info, please share :) Also, let's discuss  :D

Title: Re: What is Kymriah, the cell therapy for ALL and AML blood cancers?
Post by: chris on 12/02/2018 14:22:44

Hello James; welcome to the forum.

We discussed Kymriah on the Naked Scientists when it was licensed in September 2017.

I wrote this summary of Kymriah and how cell reprogramming therapies work (https://www.thenakedscientists.com/articles/science-news/first-reprogrammed-cell-leukaemia-therapy-approved).
 
We also spoke to Magda Papadaki, from the Association of the British Pharmaceutical Industry, who explained, in layman's terms more about how Kymriah works (https://www.thenakedscientists.com/articles/interviews/game-changer-cancer-therapy-approved).

I hope those links are helpful. Please give them a read and then return here with any follow up questions that you may have.

Chris